CABA Cabaletta Bio, Inc.
Healthcare$3.72+1.92%ClosedMarket Cap: $358.1M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$16.33
Target (Median)
$14.00
Target Range
$3.00 - $32.00
Upside from current price: 339.0%
Rating Distribution
1 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-05-04 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-03-24 | Guggenheim | maintain | Buy | Buy |
| 2026-03-24 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-10-31 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-10-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-05 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-08-14 | Citigroup | maintain | Buy | Buy |
| 2025-08-08 | Guggenheim | maintain | Buy | Buy |
| 2025-08-08 | Wells Fargo | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.27 | $712.6K | 4 |
| Sun Dec 31 | $-1.17 | $63.7M | 7 |
| Mon Dec 31 | $-0.65 | $345.7M | 2 |
| Tue Dec 31 | $0.84 | $787.6M | 5 |